Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

ProVerum, an Ireland-based benign prostatic hyperplasia therapy spinout from Trinity College Dublin, secured €30m ($34m) in a series A round yesterday. The round was co-led by Gilde Healthcare Partners and Lightstone Ventures, with commitments from unnamed existing backers. The spinout had raised $4.2m in a seed round involving University Bridge Fund, the spinout-focused venture fund managed by Atlantic Bridge, in 2018.

DeepScribe, a US-based developer of an artificial intelligence platform to automate medical notetaking based on research at University…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).